Daiichi Sankyo SWOT Analysis, Competitors & USP

Posted in Pharma and Healthcare, Total Reads: 3249

SWOT analysis of Daiichi Sankyo analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Daiichi Sankyo SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Daiichi Sankyo to benchmark its business & performance as compared to the competitors and industry. Daiichi Sankyo is one of the leading brands in the pharma and healthcare sector. The table below also lists the top Daiichi Sankyo competitors and elaborates Daiichi Sankyo market segmentation, target group, positioning & Unique Selling Proposition (USP).

Daiichi Sankyo SWOT, Competitors, Marketing STP & Brand analysis Table
Daiichi Sankyo Brand Analysis
Parent Company

Daiichi Sankyo




Pharma and Healthcare

Tagline/ Slogan

Passion for innovation, Compassion for patients


It is one of the largest pharmaceutical company in Japan

Daiichi Sankyo STP

Oncology & Cardiovascular diseases

Target Group

Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease


They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time

Daiichi Sankyo SWOT Analysis

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Daiichi Sankyo. Strengths are:

1. Has a strong workforce of over 30,000 employees

2. Leading producer of Benicar which is angiotensin II receptor antagonist

3. It is one of the largest pharmaceutical company in Japan

4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others
5. Strong brand establishment through many major acquisitions


Here are the weaknesses in the Daiichi Sankyo SWOT Analysis:

1. Despite being a strong brand, had a limited market share due to international competitors

2. Operates in limited segments such as Oncology & Cardiovascular segment


Following are the Opportunities in Daiichi Sankyo SWOT Analysis:

1. Increasing world population and more awareness about health

2. More people suffering from chronic diseases such as cancer, cardiovascular diseases

3. Increasing awareness of healthcare solutions


The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned:

1. Natural disasters in Japan

2. increasing stringency in drug development guidelines

3. Global economic slowdown

Daiichi Sankyo Competition

Below are the top 4 Daiichi Sankyo competitors:

1. Takeda Pharmaceuticals
2. Teva pharmaceuticals

3. Astellas pharmaceuticals

4. AstraZeneca

The brandguide table above concludes the Daiichi Sankyo SWOT analysis along with its marketing and brand parameters.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.

Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin